Drug firm fined for huge price rise that hit NHS

By |

This specialisation, the Advanz website boasts, “provides essential cost-savings to the NHS and wider European healthcare”. The Competition and Markets Authority’s investigation found another motivation, at least when it came to the supply of one type of thyroid tablets, which contain the chemical liothyronine, to the NHS.

Source

Previous

Chinese officials meet with Taliban as US exits Afghanistan

Tokyo Olympics: Chad le Clos’ bid for a medal ends on day six

Next

Leave a Comment